卖什么
Silvia Bio profiles mammalian cell performance in biomanufacturing to find yield bottlenecks, then supplies precision media additives that raise product titre and critical quality attributes.
商业模式拆解
工作流:什么输入变成什么输出?
Identify bottlenecks with proprietary cell profiling, then fix them with precision media additives.
渠道:怎么接触到客户?
Service platform with case studies; contact the team via Get in touch.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-10-15 | — | £3M | Northern Gritstone | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读,不是已确认的事实;未知之处留空,不作猜测。 更新于 2026-10-29.